Persimmons

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: digestion immunity heart

Research Overview

Recent persimmon research spans food chemistry, postharvest physiology, and human health–relevant bioactives. A heavily studied area is characterization of polyphenols—especially tannins and proanthocyanidins (including A-type proanthocyanidins, noted for distinct ether linkages and potential functional properties)—and how processing affects their structure and abundance. Postharvest quality preservation is another major focus, with controlled technologies such as 1-methylcyclopropene (1-MCP) repeatedly examined for delaying softening by suppressing cell wall–degrading enzymes and maintaining cell wall polysaccharides. In parallel, persimmons are frequently discussed as dietary sources of broader phytochemicals (e.g., fisetin, beta-cryptoxanthin), often within cross-food reviews that include persimmons among multiple fruits and vegetables.

The strongest evidence in these abstracts supports (i) mechanistic, experimentally grounded postharvest effects—e.g., 1-MCP treatment maintaining firmness via measurable changes in pectin/cellulose/hemicellulose fractions and reduced activities of pectin methylesterase, polygalacturonase, cellulase, and β-galactosidase—and (ii) compositional/nutritional relevance of specific compounds present in persimmon-containing diets. For example, beta-cryptoxanthin is supported by converging observational and experimental evidence as a bioavailable vitamin A precursor from common food sources including persimmons, and fisetin has substantial preclinical evidence (cell and animal models) for anticancer mechanisms such as PI3K/Akt/mTOR pathway inhibition, though these findings are not persimmon-specific. Food safety surveillance also contributes evidence: multi-class pesticide residues have been quantified in persimmons and soils in China, with most estimated consumer risks reported as low under the assessed scenarios, despite occasional exceedances of maximum residue limits.

Key gaps include persimmon-specific clinical and translational research linking defined persimmon matrices, doses, and processing states to human outcomes. Although immature persimmon tannins are suggested to have hypoglycemic activity and modern screening approaches (e.g., enzyme affinity ultrafiltration coupled to HRLC-ESI-MS/MS) are being applied to identify candidate actives, the evidence base remains incomplete in the provided abstracts (e.g., limited detail on validated targets, bioavailability, and in vivo efficacy). Additional needs include improved methods to isolate and standardize complex A-type proanthocyanidin polymers, clearer mapping of how thermal vs nonthermal processing alters bioactive architecture and function, and more comprehensive work on astringency mitigation that preserves nutritional quality while enabling broader consumer acceptance and product development.

1. What conditions has Persimmons been studied for?

  • Cancer (preclinical/observational context): Persimmon-derived compounds and persimmon-associated dietary compounds have been studied in relation to cancer biology, including colorectal cancer (CRC) cell growth/apoptosis (persimmon procyanidin dimers) and broader anticancer mechanisms for fisetin (a flavonol found in persimmons among other foods). One case-control study context also examined fruit/vegetable intake and thyroid cancer risk (not persimmon-specific in the abstract excerpt).

  • Diabetes / hypoglycemic activity (early-stage screening): Immature persimmon tannin extracts were investigated for hypoglycemic components using enzyme affinity ultrafiltration and HRLC-ESI-MS/MS (screening/identification focus).

  • Vitamin A nutrition / carotenoid status: Beta-cryptoxanthin (present in persimmons and other fruits) has been evaluated as a vitamin A–forming carotenoid with potential health relevance.

  • Food science/post-harvest quality (not a medical condition, but relevant to nutrient preservation): Studies examined persimmon softening and preservation (1-MCP treatment affecting cell wall polysaccharides/enzymes) and drying methods (freeze-drying vs infrared) affecting quality attributes and processing feasibility.

  • Food safety exposure (pesticide residues): Surveys assessed pesticide residues in persimmons and estimated short- and long-term dietary risk.

  • Polyphenols/proanthocyanidins (A-type PAs): Reviews discuss A-type proanthocyanidins (including from persimmons) and how processing can alter their structure and potential functional properties.

2. Does it work in treating those conditions? Summarize the evidence.

  • Cancer:

    • Colorectal cancer (cell studies): Two dimeric procyanidins isolated from persimmons (dimers composed of epicatechin gallate [ECG] or epigallocatechin gallate [EGCG]) inhibited growth of five human CRC cell lines and promoted apoptosis in a concentration- (10–60 μM) and time-dependent (24–72 h) manner (mechanistic preclinical evidence; not clinical efficacy).

    • Fisetin (not persimmon-specific; dietary compound found in persimmons): Reviews summarize in vitro and in vivo anticancer activity and describe fisetin as a dual inhibitor of PI3K/Akt and mTOR signaling in prostate and lung adenocarcinoma cell models, with potential as an adjuvant to chemotherapy. However, these are largely mechanistic/preclinical findings and do not establish that eating persimmons treats cancer.

    • Bottom line: Evidence in the provided abstracts supports anticancer bioactivity of specific persimmon-derived polyphenols in laboratory models, but does not demonstrate clinical treatment benefit from persimmon consumption or persimmon supplements.

  • Diabetes / blood glucose lowering:

    • The abstract states immature persimmon tannins show “high hypoglycemic activity” and describes analytical screening to identify key components (e.g., using enzyme affinity ultrafiltration and HRLC-ESI-MS/MS). The excerpt is incomplete and does not provide human outcomes, dosing, or confirmed clinical endpoints.

    • Bottom line: Suggestive early-stage evidence (component screening and implied bioactivity), but insufficient information here to conclude persimmons treat diabetes in humans.

  • Vitamin A status (via beta-cryptoxanthin):

    • A review concludes beta-cryptoxanthin-rich foods (including persimmons) likely have comparatively high bioavailability versus alpha-/beta-carotene sources, and that despite being a poorer enzyme substrate than beta-carotene, higher bioavailability may make beta-cryptoxanthin-rich foods “equivalent” sources of vitamin A in animal and human studies.

    • Bottom line: Persimmons can plausibly contribute to vitamin A nutrition as a beta-cryptoxanthin source; this is nutritional support rather than treatment of a disease.

3. What health benefits does it have?

  • Potential polyphenol-related benefits: Persimmons are identified as a favorable source of A-type proanthocyanidins (A-type PAs). The review notes A-type PAs may contribute to human nutrition and that their functional properties depend on degree of polymerization and bonding types, though it also emphasizes complexity and research gaps.

  • Antioxidant and nutrient roles via carotenoids: Persimmons are listed among foods rich in beta-cryptoxanthin, which has roles in antioxidant defense and cell-to-cell communication and serves as a vitamin A precursor important for eyesight, growth/development, and immune response.

  • Bioactive flavonoids in the diet: Persimmons are one dietary source of fisetin, a flavonol with extensive preclinical literature suggesting anticancer pathway modulation (e.g., PI3K/Akt/mTOR), though this does not prove clinical benefit from persimmon intake.

  • Potential anticancer bioactivity of persimmon-specific compounds (preclinical): Persimmon-derived ECG/EGCG dimers inhibited CRC cell growth and promoted apoptosis in multiple CRC cell lines (cell culture evidence).

  • Food technology benefit (indirect health relevance): Post-harvest interventions (e.g., 1-MCP paper treatment) can slow softening by reducing cell wall-degrading enzyme activity and preserving protopectin/cellulose/hemicellulose, potentially helping maintain fruit quality and reduce waste (quality/supply benefit rather than direct physiological benefit).

4. Does it have any downsides or side effects?

  • Pesticide residue exposure (food safety consideration):

    • In a China sampling study, pesticides (including organophosphates, organochlorines, pyrethroids, fungicides) were detected in 36.4% of persimmon samples, with concentrations reported from 1.0 μg/kg to 2945.0 μg/kg. 4.5% of persimmon samples exceeded China’s maximum residue limits (MRLs).

    • Risk assessment in that study found that, except for cyhalothrin, short-term risks for tested pesticides in fruits were below 10%, and the highest long-term risk reported was 14.13% for aldrin/dieldrin; authors concluded no significant health risk for consumers via consumption of the fruits studied. (This is context-specific and depends on region, agricultural practices, and regulatory standards.)

  • Processing-related downside (nutrient/bioactive loss): Thermal processing may negatively impact the amount and structure of A-type proanthocyanidins in the food matrix; the review suggests nonthermal technologies may better preserve these compounds. This is a “downside” mainly for retaining putative bioactives rather than a direct adverse effect.

  • Evidence gaps on adverse effects: The provided abstracts do not report clinical side effects from persimmon consumption or persimmon supplements, nor do they address common tolerability issues (so no firm conclusions can be drawn from these excerpts alone).

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic findings for persimmons (or persimmon-derived compounds) tied to specific genetic variants.

  • Potentially relevant but not addressed here: Beta-cryptoxanthin conversion to vitamin A involves carotenoid metabolism enzymes (e.g., carotenoid cleavage enzymes), and fisetin/proanthocyanidins may interact with signaling pathways; however, no genotype-stratified outcomes or variant-specific recommendations are described in the supplied abstracts.

  • Bottom line: No evidence from these abstracts that persimmons are specifically beneficial or harmful based on genetic variation.

References

  1. A-type proanthocyanidins: Sources, structure, bioactivity, processing, nutrition, and potential applications.
    Yu Zeng, Lei Zhao, Kai Wang, Catherine M G C Renard, Carine Le Bourvellec, Zhuoyan Hu, Xuwei Liu (2024) - Comprehensive reviews in food science and food safety
  2. Hypoglycemic activity of immature persimmon (Diospyros kaki Thunb.) extracts and its inhibition mechanism for α-amylase and α-glucosidase.
    Zixuan Han, Weiwei Ren, Xiaojuan Liu, Nan Lin, Jialin Qu, Xuchang Duan, Bin Liu (2024) - International journal of biological macromolecules
  3. Pesticides in persimmons, jujubes and soil from China: Residue levels, risk assessment and relationship between fruits and soils.
    Yihua Liu, Shiliang Li, Zhanglin Ni, Minghua Qu, Donglian Zhong, Caifen Ye, Fubin Tang (2016) - The Science of the total environment
  4. Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.
    Vaqar Mustafa Adhami, Deeba Nadeem Syed, Naghma Khan, Hasan Mukhtar (2012) - Biochemical pharmacology
  5. Risk assessment of
    Claude Bragard, Paola Baptista, Elisavet Chatzivassiliou, Francesco Di Serio, Paolo Gonthier, Josep Anton Jaques Miret, Annemarie Fejer Justesen, Alan MacLeod, Christer Sven Magnusson, Panagiotis Milonas, Juan A Navas-Cortes, Stephen Parnell, Roel Potting, Philippe Lucien Reignault, Emilio Stefani, Hans-Hermann Thulke, Wopke van der Werf, Jonathan Yuen, Lucia Zappalà, Élison Fabrício Bezerra Lima, David Makowski, Matteo Crotta, Alex Gobbi, Dejana Golic, Andrea Maiorano, Olaf Mosbach-Schulz, Eugenio Rossi, Anastasia Terzidou, Antonio Vicent Civera (2024) - EFSA journal. European Food Safety Authority
  6. 1-Methylcyclopropene containing-papers suppress the disassembly of cell wall polysaccharides in Anxi persimmon fruit during storage.
    Hui Wang, Yanhua Chen, Hetong Lin, Mengshi Lin, Yihui Chen, Yifen Lin (2020) - International journal of biological macromolecules
  7. Beta-cryptoxanthin as a source of vitamin A.
    Betty J Burri (2015) - Journal of the science of food and agriculture
  8. Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin.
    Deeba N Syed, Vaqar M Adhami, Mohammad Imran Khan, Hasan Mukhtar (2013) - Anti-cancer agents in medicinal chemistry
  9. Unlocking the potential of persimmons: A comprehensive review on emerging technologies for post-harvest challenges, processing innovations, and prospective applications.
    Yangyang Jia, Zhen Wang, Xinhong Liang, Cunjian Tu, Ibrahim Khalifa, Chuang Wang, Yingheng Zhu, Haoyu Chen, Lanlan Hu, Chunmei Li (2024) - Food chemistry
  10. Assessment of freeze, continuous, and intermittent infrared drying methods for sliced persimmon.
    Ahmet Polat, Onur Taskin, Nazmi Izli (2024) - Journal of food science
  11. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
    Wei Zhu, Mei C Li, Feng R Wang, Gerardo G Mackenzie, Patricia I Oteiza (2020) - Biochemical pharmacology
  12. The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways.
    Thamaraiselvan Rengarajan, Nik Soriani Yaacob (2016) - European journal of pharmacology
  13. Ethyl Formate Fumigation for Control of the Scale Insect
    Tae-Hyung Kwon, Jin-Hun Cho, Dong-Bin Kim, Gi-Myon Kwon, Ki-Jeong Hong, Yonglin Ren, Byung-Ho Lee, Min-Goo Park (2023) - Insects
  14. The effect of raw vegetable and fruit intake on thyroid cancer risk among women: a case-control study in South Korea.
    Su Kyoung Jung, Kirang Kim, Kyung Tae, Gu Kong, Mi Kyung Kim (2013) - The British journal of nutrition
  15. Physicochemical and Volatile Compounds Analysis of Fruit Wines Fermented with
    Paweł Paśko, Agnieszka Galanty, Tomasz Dymerski, Young-Mo Kim, Yong-Seo Park, Patricia Cabrales-Arellano, Victor Velazquez Martinez, Efren Delgado, Mikołaj Gralak, Joseph Deutsch, Dinorah Barasch, Alina Nemirovski, Shela Gorinstein (2024) - International journal of molecular sciences
  16. Estimation of dietary total antioxidant capacity of Korean adults.
    Shinyoung Jun, Ock K Chun, Hyojee Joung (2018) - European journal of nutrition
  17. Molecular Targets of Tannic Acid in Alzheimer's Disease.
    Nady Braidy, Bat-Erdene Jugder, Anne Poljak, Tharusha Jayasena, Seyed Mohammad Nabavi, Perminder Sachdev, Ross Grant (2017) - Current Alzheimer research
  18. Intake and major sources of dietary flavonoid in Korean adults: Korean National Health and Nutrition Examination Survey 2010-2012.
    You Jin Kim, Min Young Park, Namsoo Chang, Oran Kwon (2015) - Asia Pacific journal of clinical nutrition
  19. Dissipation and Residue Pattern of Dinotefuran, Fluazinam, Indoxacarb, and Thiacloprid in Fresh and Processed Persimmon Using LC-MS/MS.
    Hyun-Ho Noh, Seung-Hyeon Jo, Hyeon-Woo Shin, Dong-Ju Kim, Young-Jin Ham, Jun-Young Kim, Dan-Bi Kim, Hye-Young Kwon, Kee-Sung Kyung (2022) - Foods (Basel, Switzerland)
  20. Effect of deastringency treatment of intact persimmon fruits on the quality of fresh-cut persimmons.
    Hun-Sik Chung, Han-Soo Kim, Young-Guen Lee, Jong-Hwan Seong (2015) - Food chemistry


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!